Associate Clinical Professor (Voluntary) of Plastic Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
private practice in Beverly Hills, CA.
Aesthet Surg J. 2021 Jan 1;41(1):98-108. doi: 10.1093/asj/sjaa287.
A moratorium was placed on nonurgent surgery throughout much of the United States in mid-March 2020 due to surging numbers of COVID-19 cases. Several months later, and with new safety precautions in place, elective surgery gradually resumed. However, no data exist on the safety of plastic surgery during the pandemic.
This aim of this survey was to assess the safety of plastic surgery during the pandemic by quantifying: (1) the preoperative prevalence of SARS-CoV-2; (2) the risk of postoperative COVID-19; (3) outcomes and precious resource utilization for such cases; and (4) the risks to office staff.
Los Angeles plastic surgeons certified by the American Board of Plastic Surgery (ABPS) were sent an online survey in July 2020, during a local COVID-19 surge, querying about the number of procedures performed in the 8- to 10-week period since reopening, testing policies, surgical complications, and cases among staff.
In total, 112 surgeons reported 5633 surgeries since resuming elective surgery. Of these, 103 (91.96%) surgeons obtained a preoperative SARS-CoV-2 polymerase chain reaction (PCR) test for every patient. The preoperative PCR test was positive in 41/5881 (0.69%). Positive tests within 2 weeks postoperation occurred in 7/5380 (0.13%) of surgical patients, 3/8506 (0.04%) of injection patients, and 6/2519 (0.24%) of energy therapy patients. Nine offices reported at least 1 staff member who developed COVID-19. All cases were mild, with no hospitalizations or deaths.
These data demonstrate that plastic surgery can be performed safely during a COVID-19 surge by ABPS diplomates. This has profound impact for patients, plastic surgeons, and health policy regulators.
由于 COVID-19 病例数量激增，2020 年 3 月中旬，美国大部分地区暂停了非紧急手术。几个月后，随着新的安全措施的实施，择期手术逐渐恢复。然而，目前尚无关于大流行期间整形手术安全性的数据。
本调查旨在通过量化以下方面评估大流行期间整形手术的安全性：（1）术前 SARS-CoV-2 的流行率；（2）术后 COVID-19 的风险；（3）此类病例的结果和宝贵资源利用情况；（4）办公室工作人员的风险。
2020 年 7 月，在当地 COVID-19 疫情高峰期，向美国整形外科委员会（ABPS）认证的洛杉矶整形外科医生发送了一份在线调查，询问他们在重新开放后的 8-10 周内进行了多少例手术、检测政策、手术并发症和员工中的病例。
共有 112 名外科医生报告了自恢复择期手术以来的 5633 例手术。其中，103 名（91.96%）外科医生对每位患者进行了术前 SARS-CoV-2 聚合酶链反应（PCR）检测。5881 例患者中有 41 例（0.69%）术前 PCR 检测呈阳性。术后 2 周内，手术患者中 7/5380（0.13%）、注射患者中 3/8506（0.04%）、能量治疗患者中 6/2519（0.24%）的检测结果呈阳性。有 9 个办公室报告至少有 1 名工作人员感染了 COVID-19。所有病例均为轻症，无住院或死亡。
这些数据表明，ABPS 认证的外科医生可以在 COVID-19 疫情高峰期安全地进行整形手术。这对患者、整形外科医生和卫生政策监管机构都具有深远的影响。
